Results 231 to 240 of about 335,095 (291)

Time Trends and Predictors of Gout Remission Over 6 Years

Arthritis Care &Research, EarlyView.
Objective This study aims to describe the trends in remission rates over 6 years of follow‐up among people with gout taking urate‐lowering therapy (ULT) and to identify variables that predict remission. Methods A post hoc analysis was conducted using data from the Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout (CARES) trial ...
Adwoa Dansoa Tabi‐Amponsah, Sarah Stewart, Greg Gamble, Lisa K. Stamp, William J. Taylor, Nicola Dalbeth   +5 more
wiley   +1 more source

Association of coronary artery calcium score with cardiovascular events: a retrospective study. [PDF]

Quant Imaging Med Surg
Yu X, Li G, Yin W, Hu J.
europepmc   +1 more source

Replication Data for: Proper Specification of Non-proportional Hazards Corrections in Duration Models JB_PA2016_ChiozzaGoemans2004-reanalysis-part2.tex

, 2016
Shuai Frederick J. Boehmke Jin
openalex   +2 more sources

Development of a personalized visualization and analysis tool to improve clinical care in complex multisystem diseases with application to scleroderma

Arthritis Care &Research, Accepted Article.
Background In complex diseases, it is challenging to assess a patient's disease state, trajectory, treatment exposures, and risk of multiple outcomes simultaneously, efficiently and at the point of care. Methods We developed an interactive patient‐level data visualization and analysis tool (VAT) that automates illustration of a scleroderma patient's ...
Ji Soo Kim, John Scott, Lauren Fisher, Lauren N. Smith, Willie Stewart, Adrianne Woods, Rob Smithwright, Diane Koher, Parastoo Aslanbeik, Aalok B. Shah, Brad Tibbils, Samantha I. Pitts, Ayse P. Gurses, Yushi Yang, Ana‐Maria Orbai, Antony Rosen, Laura K. Hummers, Scott L. Zeger, Ami A. Shah   +18 more
wiley   +1 more source

Replication Data for: Proper Specification of Non-proportional Hazards Corrections in Duration Models

, 2016
Shuai Frederick J. Boehmke Jin
openalex   +2 more sources

Hydroxychloroquine Associated with Lower Glomerular Filtration Rate Decline in Lupus Nephritis

Arthritis Care &Research, Accepted Article.
Background Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical. Therefore, we analyzed data from our
Shivani Garg, Brad Rovin, Brad C. Astor, Tripti Singh, Fauzia Hollnagel, Megan Kuik, Lexie Kolton, Callie Saric, S. Sam Lim, Christie M. Bartels   +9 more
wiley   +1 more source

Albumin level and risk of major bleeding in patients with atrial fibrillation on direct oral anticoagulants. [PDF]

Eur Heart J Cardiovasc Pharmacother
Sasaki S, Sakamoto D, Matsuoka Y, Okada K, Sunaga A, Nakatani D, Kioka H, Kanda T, Minamiguchi H, Watanabe R, Nagashima K, Higuchi Y, Okumura Y, Sotomi Y, Sakata Y.   +14 more
europepmc   +1 more source

A Simple Test for the Absence of Covariate Dependence in Hazard Regression Models [PDF]

, 2007
Bhattacharjee, Arnab
core   +1 more source

Global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis burden, 1990–2021

Arthritis Care &Research, Accepted Article.
Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rate for site‐specific OA across 204 countries/territories were obtained from the Global Burden of Diseases Study (GBD) 2021.
Haowei Chen, Lei Si, David J Hunter, Lei Zhang, Zhe‐Sheng Chen, Xiaomeng Wang, Vicky Duong, Zhounan Zhou, Peihua Cao, Han Cen, Su'an Tang, Tianyu Chen, Houjun Xue, Zhaohua Zhu, Changhai Ding   +14 more
wiley   +1 more source

Predicting time-to-first cancer diagnosis across multiple cancer types. [PDF]

Sci Rep
Lau K, Hart GR, Deng J.
europepmc   +1 more source